Clinical Study of OR for Second-line Treatment of Refractory MZL

Clinical trial NCT06134284 · RECRUITING

Trial details

NCT number: NCT06134284
Sponsor: Lixia Sheng
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

OR Regimen for Relapsed/Refractory Marginal Zone Lymphoma

Start date: 2023-01-02
Primary completion: 2026-12-31
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.